Recomienda este artículo a tus amigos:
Monkeys in the Middle: How One Drug Company Kept a Parkinsons Disease Breakthrough out of Reach Nick Nelson
Precio
Mex$ 386
sin IVA
Pedido desde almacén remoto
Entrega prevista 1 - 17 de sep.
Recibe notificaciones sobre nuevos lanzamientos de Nick Nelson
Nuestros clientes opinan:
Añadir a tu lista de deseos de iMusic
Monkeys in the Middle: How One Drug Company Kept a Parkinsons Disease Breakthrough out of Reach
Nick Nelson
Some said it was a miracle drug; others called it the cure. A drug known simply as "GDNF" seemed to do the impossible by actually reversing the effects of Parkinson's disease. The miracle ended in the fall of 2004 when Amgen Inc. abruptly halted clinical trials of GDNF and denied access to the drug. In "Monkeys in the Middle", investigative reporter Nick Nelson recounts the true story of the brave patients who took on the world's biggest biotechnology company for the right to be kept alive.
| Medios de comunicación | Libros Paperback Book (Libro con tapa blanda y lomo encolado) |
| Publicado | 27 de mayo de 2008 |
| ISBN13 | 9781419696558 |
| Editores | BookSurge Publishing |
| Páginas | 272 |
| Dimensiones | 150 × 14 × 226 mm · 367 g |
| Lengua | Inglés |
